Author

Wouter Van Moerkercke 1

1 AZ Groeninge,Kortrijk,Belgium

Effect of vedolizumab dose intensification on serum drug concentrations and regain of response in inflammatory bowel disease patients with secondary loss of response

An Outtier, Jean François Rahier, Peter Bossuyt, Arnaud Colard, Denis Franchimont, Guy Lambrecht, Elisabeth Macken, Wouter Van Moerkercke, Filip Baert, Evelien Humblet, Philippe Van Hootegem, Ann Gils, Marc Ferrante, Severine Vermeire

Integrin expression changes on the T cell subsets influence the response to vedolizumab in inflammatory bowel disease patients

Cara De Galan, Sophie Van Welden, Simon Bos, Simon Tavernier, Triana Lobaton Ortega, Gerard Gonzales, Wouter Van Moerkercke, Beatrijs Strubbe, Harald Peeters, Elisabeth Macken, Martine De Vos, Debby Laukens, Pieter Hindryckx

SELECTING IBD PATIENTS WHO WILL BENEFIT FROM THROMBOPROPHYLAXIS THROUGH A RISK ASSESSMENT THAT INCLUDES CLOT LYSIS PARAMETERS AND CLINICAL ASSESSMENT

Lize Bollen, Niels Vande Casteele, Wouter Van Moerkercke, Marc Ferrante, Severine Vermeire, Ann Gils

Item 1 - 3 / 4
1